Forum Πρωτοβάθμιας Φροντίδας Υγείας
ΠΦΥ -Εκπαίδευση => Αποσπάσματα από τον έντυπο & ηλεκτρονικό τύπο => Μήνυμα ξεκίνησε από: Argirios Argiriou στις 17 Ιουνίου 2022, 09:36:20
-
Journal Watch, 07 June 2022
Should Patients with New Diabetes Receive SGLT-2 Inhibitors Before Metformin?
Daniel D. Dressler, MD, MSc, MHM, FACP, reviewing Shin H et al. Ann Intern Med 2022 May 24
Although those who initiated sodium–glucose cotransporter-2 inhibitors had fewer hospitalizations for heart failure, starting these agents before metformin is not indicated.
https://www.jwatch.org/na54976/2022/06/07/should-patients-with-new-diabetes-receive-sglt-2?query=topic_diabetes&jwd=000100032085&jspc=GP&cid=DM1160659_Non_Subscriber&bid=1029885414 (https://www.jwatch.org/na54976/2022/06/07/should-patients-with-new-diabetes-receive-sglt-2?query=topic_diabetes&jwd=000100032085&jspc=GP&cid=DM1160659_Non_Subscriber&bid=1029885414)